{
     "PMID": "24861264",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20141229",
     "LR": "20140809",
     "IS": "1879-1220 (Electronic) 0960-0760 (Linking)",
     "VI": "143",
     "DP": "2014 Sep",
     "TI": "Neonatal allopregnanolone or finasteride administration modifies hippocampal K(+) Cl(-) co-transporter expression during early development in male rats.",
     "PG": "343-7",
     "LID": "10.1016/j.jsbmb.2014.05.002 [doi] S0960-0760(14)00104-6 [pii]",
     "AB": "The maintenance of levels of endogenous neurosteroids (NS) across early postnatal development of the brain, particularly to the hippocampus, is crucial for their maturation. Allopregnanolone (Allop) is a NS that exerts its effect mainly through the modulation of the GABAA receptor (GABAAR). During early development, GABA, acting through GABAAR, that predominantly produces depolarization shifts to hyperpolarization in mature neurons, around the second postnatal week in rats. Several factors contribute to this change including the progressive increase of the neuron-specific K(+)/Cl(-) co-transporter 2 (KCC2) (a chloride exporter) levels. Thus, we aimed to analyze whether a different profile of NS levels during development is critical and can alter this natural progression of KCC2 stages. We administrated sustained Allop (20mg/kg) or Finasteride (5alpha-reductase inhibitor, 50mg/kg) from the 5th postnatal day (PD5) to PD9 and assessed changes in the hippocampal expression of KCC2 at transcript and protein levels as well as its active phosphorylated state in male rats. Taken together data indicated that manipulation of NS levels during early development influence KCC2 levels and point out the importance of neonatal NS levels for the hippocampal development.",
     "CI": [
          "Copyright (c) 2014 Elsevier Ltd. All rights reserved."
     ],
     "FAU": [
          "Modol, Laura",
          "Casas, Caty",
          "Llido, Anna",
          "Navarro, Xavier",
          "Pallares, Marc",
          "Darbra, Sonia"
     ],
     "AU": [
          "Modol L",
          "Casas C",
          "Llido A",
          "Navarro X",
          "Pallares M",
          "Darbra S"
     ],
     "AD": "Group of Neurosteroids and Behaviour, Institut de Neurociencies, Departament de Psicobiologia i Metodologia de les Ciencies de la Salut, Universitat Autonoma de Barcelona, 08193 Bellaterra, Barcelona, Spain. Group of Neuroplasticity and Regeneration, Institut de Neurociencies and Department of Cell Biology, Physiology and Immunology, Universitat Autonoma de Barcelona, and Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), 08193 Bellaterra, Barcelona, Spain. Group of Neurosteroids and Behaviour, Institut de Neurociencies, Departament de Psicobiologia i Metodologia de les Ciencies de la Salut, Universitat Autonoma de Barcelona, 08193 Bellaterra, Barcelona, Spain. Group of Neuroplasticity and Regeneration, Institut de Neurociencies and Department of Cell Biology, Physiology and Immunology, Universitat Autonoma de Barcelona, and Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), 08193 Bellaterra, Barcelona, Spain. Group of Neurosteroids and Behaviour, Institut de Neurociencies, Departament de Psicobiologia i Metodologia de les Ciencies de la Salut, Universitat Autonoma de Barcelona, 08193 Bellaterra, Barcelona, Spain. Group of Neurosteroids and Behaviour, Institut de Neurociencies, Departament de Psicobiologia i Metodologia de les Ciencies de la Salut, Universitat Autonoma de Barcelona, 08193 Bellaterra, Barcelona, Spain. Electronic address: sonia.darbra@uab.cat.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20140523",
     "PL": "England",
     "TA": "J Steroid Biochem Mol Biol",
     "JT": "The Journal of steroid biochemistry and molecular biology",
     "JID": "9015483",
     "RN": [
          "0 (5-alpha Reductase Inhibitors)",
          "0 (Anesthetics)",
          "0 (RNA, Messenger)",
          "0 (Receptors, GABA-A)",
          "0 (Symporters)",
          "0 (potassium-chloride symporters)",
          "57GNO57U7G (Finasteride)",
          "BXO86P3XXW (Pregnanolone)"
     ],
     "SB": "IM",
     "MH": [
          "5-alpha Reductase Inhibitors/*administration & dosage/pharmacology",
          "Anesthetics/administration & dosage/pharmacology",
          "Animals",
          "Animals, Newborn",
          "Cells, Cultured",
          "Finasteride/*administration & dosage/pharmacology",
          "Hippocampus/cytology/drug effects/*metabolism",
          "Male",
          "Neurons/cytology/drug effects/*metabolism",
          "Pregnanolone/*administration & dosage/pharmacology",
          "RNA, Messenger/genetics",
          "Rats",
          "Rats, Wistar",
          "Real-Time Polymerase Chain Reaction",
          "Receptors, GABA-A/genetics/*metabolism",
          "Reverse Transcriptase Polymerase Chain Reaction",
          "Symporters/genetics/*metabolism"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Development",
          "GABAA receptor",
          "Hippocampus",
          "Intra cellular chloride",
          "Neurosteroids",
          "Rat"
     ],
     "EDAT": "2014/05/28 06:00",
     "MHDA": "2014/12/30 06:00",
     "CRDT": [
          "2014/05/28 06:00"
     ],
     "PHST": [
          "2014/01/11 00:00 [received]",
          "2014/05/05 00:00 [revised]",
          "2014/05/06 00:00 [accepted]",
          "2014/05/28 06:00 [entrez]",
          "2014/05/28 06:00 [pubmed]",
          "2014/12/30 06:00 [medline]"
     ],
     "AID": [
          "S0960-0760(14)00104-6 [pii]",
          "10.1016/j.jsbmb.2014.05.002 [doi]"
     ],
     "PST": "ppublish",
     "SO": "J Steroid Biochem Mol Biol. 2014 Sep;143:343-7. doi: 10.1016/j.jsbmb.2014.05.002. Epub 2014 May 23.",
     "term": "hippocampus"
}